COVID-19 drug trial pulled before it started
Disease control
Terminated
This study was designed to test whether the drug itolizumab could help hospitalized COVID-19 patients recover faster. The trial was planned for 18 years and older with confirmed COVID-19 pneumonia and low oxygen levels. However, the study was withdrawn before enrolling any partic…
Phase: PHASE3 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC